Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study
Article in PLOS ONE (May 2023)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non-small cell lung cancer.
Article in Journal of Managed Care & Specialty Pharmacy (December 2021)
Hyphenated mass spectrometry techniques for assessing medication adherence: advantages, challenges, clinical applications and future perspectives
Article in Clinical Chemistry and Laboratory Medicine (January 2020)